Evidence map›Paper›PMID 23651852›Full record

ArticleGenes & development2013

RB goes mitochondrial.

Laura D Attardi, Julien Sage

Open access · diamondAbstract readComment
In one paragraph

Article in Genes & development, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Laura D AttardiDepartment of Radiation Oncology, Stanford University, Stanford, California 94305, USA.
Julien Sage
Stanford University · US

Funding

The RB pathway in liver cancerR01CA114102 · NCI · STANFORD UNIVERSITY · PI SAGE, JULIEN · 2006 to 2016
$2.9M
Mouse Models to Dissect p53 Tumor Suppressor FunctionR01CA140875 · NCI · STANFORD UNIVERSITY · PI ATTARDI, LAURA D · 2011 to 2015
$1.7M
Elucidating p53 transcriptional networks involved in pancreatic cancer suppressioR21CA169673 · NCI · STANFORD UNIVERSITY · PI ATTARDI, LAURA D · 2012 to 2013
$368k
NCI NIH HHS R01 CA114102NCI NIH HHS R01CA114102NCI NIH HHS R01 CA140875NCI NIH HHS R21 CA169673
6 · The paper itself

Abstract

The retinoblastoma tumor suppressor RB is well known for its capacity to restrict cell cycle progression at the G1/S transition of the cell cycle by controlling the transcription of cell cycle genes. In this issue of Genes & Development, Hilgendorf and colleagues (pp. 1003-1015) have identified a novel tumor suppressor function for RB independent of its role as a transcriptional regulator, in which RB directly activates the apoptosis regulator Bax at the mitochondria to promote cell death.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsApoptosisHumansMitochondriaRetinoblastoma ProteinRetinoblastoma ProteinapoptosiscancerMOMPpRBretinoblastoma protein

Identifiers

PMID23651852
PMCPMC3656326
OpenAlexW2162972982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.